B. Hepatitis,

, World Health Organization, 2018.

C. E. Stevens, R. P. Beasley, J. Tsui, and W. C. Lee, Vertical transmission of hepatitis B antigen in Taiwan

J. Engl and . Med, , vol.292, pp.771-775, 1975.

D. Xu, Y. Yan, B. Choi, J. Xu, K. Men et al., Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study, J Med Virol, vol.67, issue.1, pp.20-26, 2002.

V. C. Wong, A. K. Lee, and H. M. Ip, Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant, Br J Obstet Gynaecol, vol.87, issue.11, pp.958-65, 1980.

M. Sunbul, Hepatitis B virus genotypes: global distribution and clinical importance, World J Gastroenterol, vol.20, issue.18, pp.5427-5461, 2014.
DOI : 10.3748/wjg.v20.i18.5427

URL : https://doi.org/10.3748/wjg.v20.i18.5427

R. P. Beasley, L. Y. Hwang, G. C. Lee, C. C. Lan, C. H. Roan et al., Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine, Lancet, 1983.

, Nov, vol.12, issue.8359, pp.1099-102

K. Lo, Y. Tsai, S. Lee, T. Wu, J. Wang et al., Immunoprophylaxis of Infection with

, Hepatitis B Virus in Infants Born to Hepatitis B Surface Antigen-Positive Carrier Mothers, Journal of Infectious Diseases, vol.152, issue.4, pp.817-839, 1985.

H. Hsu, D. Chen, C. Chuang, J. Lu, D. Jwo et al., Efficacy of a Mass Hepatitis B Vaccination Program in Taiwan: Studies on 3464 Infants of Hepatitis B Surface Antigen-Carrier Mothers

, JAMA, vol.260, issue.15, pp.2231-2236, 1988.

H. Chen, L. Lin, F. Hu, J. Lee, W. Lin et al., Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV, Gastroenterology, 2012.

L. Zhang, X. Gui, C. Teter, H. Zhong, Z. Pang et al., Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine. Vaccine, vol.32, pp.6091-6098, 2014.

C. Q. Pan, Z. Duan, E. Dai, S. Zhang, G. Han et al., Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load, N Engl J Med, vol.374, issue.24, pp.2324-2358, 2016.

G. Jourdain, N. Ngo-giang-huong, L. Harrison, L. Decker, W. Khamduang et al., Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B, N Engl J Med, vol.378, issue.10, pp.911-934, 2018.

A. Xeuatvongsa, K. Komada, T. Kitamura, P. Vongphrachanh, C. Pathammavong et al.,

, Chronic Hepatitis B Prevalence among Children and Mothers: Results from a Nationwide, Population-Based Survey in Lao People's Democratic Republic, PLoS ONE, vol.9, issue.2, p.88829, 2014.

A. P. Black, P. Nouanthong, N. Nanthavong, C. Souvannaso, K. Vilivong et al., Hepatitis B virus in the Lao People's Democratic Republic: a cross sectional serosurvey in different cohorts, BMC Infect Dis, vol.14, p.457, 2014.

M. Choisy, S. Keomalaphet, K. Xaydalasouk, F. Quet, and V. Latthaphasavang,

, Hepatitis B Virus Infection among Pregnant Women Attending Antenatal Clinics in Vientiane, 2008.

H. Research and . Treatment, Hepatitis B vaccine birthdose practices in a country where hepatitis B is endemic -Laos, MMWR Morb Mortal Wkly Rep, vol.2017, issue.29, pp.587-90, 2011.

C. Lee, Y. Gong, J. Brok, E. H. Boxall, and C. Gluud, Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis, BMJ, vol.332, issue.7537, pp.328-364, 2006.

P. Jutavijittum, I. E. Andernach, A. Yousukh, B. Samountry, K. Samountry et al., Occult hepatitis B infections among blood donors in Lao PDR, Vox Sang, vol.106, issue.1, pp.31-38, 2014.

G. Han, M. Cao, W. Zhao, H. Jiang, C. Wang et al., A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection, J Hepatol, vol.55, issue.6, pp.1215-1236, 2011.

H. Chen, C. Lee, C. Chang, Y. Ni, M. Shyu et al., Efficacy of maternal tenofovir disoproxil fumarate in interrupting mother-to-infant transmission of hepatitis B virus, Hepatology, 2015.

G. Han, H. Jiang, X. Yue, Y. Ding, C. Wang et al., Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection, J Viral Hepat, vol.22, issue.9, pp.754-62, 2015.

K. W. Cheung, M. Seto, A. Kan, D. Wong, K. O. Kou et al.,

, Infants Born to Hepatitis B Carrier Mothers Following Routine Vaccination, Clin Gastroenterol Hepatol, 2018.

P. Jutavijittum, A. Yousukh, B. Saysanasongkham, B. Samountry, K. Samountry et al., Southeast Asian J Trop Med Public Health, vol.47, issue.2, pp.214-222, 2016.

G. Han, H. Jiang, C. Wang, Y. Ding, G. Wang et al., Longterm safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy, Journal of Viral Hepatitis, vol.24, issue.6, pp.514-535, 2017.

A. Mlm_module1-;-theamboonlers, V. Chongsrisawat, P. Jantaradsamee, and Y. Poovorawan, Variants within the "a" determinant of HBs gene in children and adolescents with and without hepatitis B vaccination as part of, 2018.

, Thailand's Expanded Program on Immunization (EPI), Tohoku J Exp Med, vol.193, issue.3, pp.197-205, 2001.

N. Ogata, P. J. Cote, A. R. Zanetti, R. H. Miller, M. Shapiro et al., Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus, Hepatology, vol.30, issue.3, pp.779-86, 1999.

W. Khamduang, C. Gaudy-graffin, N. Ngo-giang-huong, G. Jourdain, A. Moreau et al.,

, Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring, J Clin Virol, vol.58, issue.2, pp.415-436, 2013.

B. Yan, J. Lv, Y. Feng, J. Liu, J. F. Xu et al., Temporal trend of hepatitis B surface mutations in the post-immunization period: 9 years of surveillance, eastern China. Scientific Reports, 2005.

M. E. Dec-;-hellard, R. Chou, and P. Easterbrook, WHO guidelines on testing for hepatitis B and C -meeting targets for testing. BMC Infectious Diseases, vol.7, 2017.